Thomas Freeburg

Chief Financial Officer, Niki BioSolutions, Inc.

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Thomas Freeburg has been Chief Financial Officer of Niki BioSolutions, Inc. since September 1, 2026, according to the company's filing of October 13, 2026.¹

The filing gives Thomas Freeburg's previous role as Managing Member at Cambridge Accounting Group, LLC.¹ Thomas Freeburg joined from outside Niki BioSolutions, Inc., by the record's reading of the filing.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Niki BioSolutions, Inc. (NIKI) Measuring & Controlling Devices, NEC	Chief Financial Officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

September 1, 2026effective
Niki BioSolutions, Inc. appointed Thomas Freeburg as Chief Financial Officer, effective September 1, 2026.
On October 9, 2026, the Board of Directors (the “Board”) of Niki BioSolutions, Inc., a Delaware corporation (the “Company”), appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period […]
[1] Filing by Niki BioSolutions, Inc., filed with the SEC on October 13, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, Niki BioSolutions, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed October 13, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Thomas Freeburg wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.